Christine Henrico

Global Commercial Lead, Enzyme Replacement Therapies And PKU Franchises at BioMarin Pharmaceutical

Christine Henrico, MBA, is a seasoned global commercialization leader currently serving as the Global Commercial Lead for Enzyme Replacement Therapies and PKU Franchises at BioMarin Pharmaceutical Inc. since September 2023. With extensive experience in the pharmaceutical industry, Christine previously held the role of Vice President of Marketing at Avanir Pharmaceuticals, overseeing CNS therapeutic strategies and product development. Prior positions include Global Commercial Leader for Rare Diseases at Shire, where Christine prepared the organization for product launches, and Global Portfolio Commercialization Leader at Takeda, where Christine developed strategies for a $1B gastrointestinal franchise. Christine's career began at Eli Lilly and Company, where Christine held various roles, including commercialization leader for cardiovascular products and district sales manager in the neuroscience division. Christine holds an MBA in Marketing from the University of North Carolina at Chapel Hill and a BA in Economics from Concordia University.

Links